Standard first-line drug therapies for the treatment of bone density disorders have been linked to higher risk of experiencing a cardiovascular event, according to a study published June 26 in Epic ...

Treatment with romosozumab is linked to improved BMD and a reduced risk for vertebral fractures among postmenopausal women with osteoporosis.

It’s a “silent” disease that affects millions of people as they age.Today’s conversation focuses on osteoporosis.St. Joseph’s ...

In addition, patients should be prescribed a bisphosphonate, according to the 2002 Canadian osteoporosis guidelines [11] (since they will require greater than 3 months of at least 7.5 mg ...